New Delhi: The Indian Council of Medical Research Director General Dr Rajiv Bahl on Monday criticised a recently published study on the long-term safety analysis of the Covaxin in adults and adolescents for its poor methodology and design, and clarified the article misleadingly and erroneously "acknowledges" ICMR. A research paper, titled 'Long-Term Safety Analysis of the BBVl52 Coronavirus Vaccine in …
The country’s apex biomedical research regulator, the Indian Council of Medical Research, has distanced itself from a Banaras Hindu University study that raised concerns on safety of Bharat Biotech’s Covid vaccine, Covaxin, and threatened legal action against the study’s authors for acknowledging ICMR’s support for a poorly designed study without its consent. ICMR chief Rajiv Bahl has formally written to …
Age and co-morbidity are definite factors that affect the outcome of contracting COVID-19, Rajiv Bahl, Director General of the Indian Council of Medical Research, has said. We should be able to share the information by this month-end,” Dr. Bahl said on the sidelines of the recently held G-20 meeting on health. Speaking on the work done to help bring in …
Mumbai: Preliminary work for the sixth round of the National Family Health Survey has begun, Dr Rajiv Bahl, secretary of department of health research and director general of Indian Council of Medical Research, announced. “The field survey will be launched in June, and by the next year we will have the results,” said professor KS James, director of the institute …
